Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to prioritise people with (a) asthma and (b) other respiratory conditions for the covid-19 booster vaccination.
The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:
The JCVI advises a two staged approach, with individuals in stage one offered a booster and flu vaccine, as soon as possible from September. Individuals in stage two should be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. Adults aged over 50 years old and those aged 16 to 49 years old who are in an influenza or COVID-19 at-risk group, are included in stage two. Influenza at-risk groups include some sufferers of chronic respiratory disease, such as asthma.
Final decisions on the timing and scope of the vaccine booster programme, as well as cohorts and eligibility, will be made later in the year, informed by further independent advice from the JCVI.